With over 50% of the antibodies GMAb develops being used in flow cytometry, we offer flow cytometry screening at each phase of development to provide data for on-cell binding. The screening capability is provided by our Attune NxT Flow Cytometer. This high-throughput machine allows us to design, run and analyze during antibody development.
Projects which benefit from our flow cytometer include:
- CAR-T specific detection
- Anti-idiotypic neutralizing (Nab) assays for cell surface markers where soluble antigen is not available
- Confirm cell binding in real time for therapeutic targets
- Measure mAb internalization
Our goal is to identify the best-fit antibodies by screening with the correct method earlier in the process. Your budget and timeline depend on it.
Not sure what you need?
Our expert team will guide you every step of the way.